iScience (Sep 2023)

Human adipose ECM alleviates radiation-induced skin fibrosis via endothelial cell-mediated M2 macrophage polarization

  • Somaiah Chinnapaka,
  • Katherine S. Yang,
  • Yusuf Surucu,
  • Fuat B. Bengur,
  • José A. Arellano,
  • Zayaan Tirmizi,
  • Hamid Malekzadeh,
  • Michael W. Epperly,
  • Wen Hou,
  • Joel S. Greenberger,
  • J. Peter Rubin,
  • Asim Ejaz

Journal volume & issue
Vol. 26, no. 9
p. 107660

Abstract

Read online

Summary: Radiation therapy can lead to late radiation-induced skin fibrosis (RISF), causing movement restriction, pain, and organ dysfunction. This study evaluated adipose-derived extracellular matrix (Ad-ECM) as a mitigator of RISF. Female C57BL/6J mice that were irradiated developed fibrosis, which was mitigated by a single local Ad-ECM injection, improving limb movement and reducing epithelium thickness and collagen deposition. Ad-ECM treatment resulted in decreased expression of pro-inflammatory and fibrotic genes, and upregulation of anti-inflammatory cytokines, promoting M2 macrophage polarization. Co-culture of irradiated human fibroblasts with Ad-ECM down-modulated fibrotic gene expression and enhanced bone marrow cell migration. Ad-ECM treatment also increased interleukin (IL)-4, IL-5, and IL-15 expression in endothelial cells, stimulating M2 macrophage polarization and alleviating RISF. Prophylactic use of Ad-ECM showed effectiveness in mitigation. This study suggests Ad-ECM’s potential in treating chronic-stage fibrosis.

Keywords